Clinical Trials Browser

Phase NA × Leukemia, Myeloid, Acute × Daunorubicin × Clear all

NCT07131059 2025-08-20

MRD-positive AML Clinical Study

Phase NA Recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute, Neoplasm, Residual

NCT06697327 2025-05-14

Daunorubicin + Cytarabine + Venetoclax in de Novo AML

Phase NA Enrolling by invitation

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT02432872 2016-10-07

Treatment of Older Adult Acute Myeloid Leukemia Patients Aged 55 to 65 Years

Phase NA Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute